Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342742 · ClinicalTrials.gov registry record · NA
Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
A NA study of Polycystic Kidney, Autosomal Dominant, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03342742 is a NA study of Polycystic Kidney, Autosomal Dominant that has completed, run by University of Colorado, Denver. The registered enrollment target is 29 participants, below the 70-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03342742, a NA study of Polycystic Kidney, Autosomal Dominant, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will determine the feasibility of delivering two behavioral weight loss interventions for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will also compare these two interventions in terms of safety, acceptability, and tolerability. Last, this pilot trial will provide initial insight into a) biological changes and b) changes in kidney growth with each of the two weight loss interventions.
Conditions Studied
Interventions
- BEHAVIORAL Weight Loss
Study Locations (1)
Colorado
- Kristen Nowak - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2020-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03342742
The ClinicalTrials.gov registry entry for NCT03342742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 70-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (59% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Polycystic Kidney, Autosomal Dominant appearing as the primary indexed condition, and to 1 intervention - of which Weight Loss is the first listed.
NCT03342742 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03342742 about?
NCT03342742 is a clinical study titled "Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease". The proposed research will determine the feasibility of delivering two behavioral weight loss interventions for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will also compare these two interventions in terms of safety, acceptabilit...
What is the current status of trial NCT03342742?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-06-04. Estimated completion is 2020-10-13.
What conditions does trial NCT03342742 study?
This clinical trial studies the following conditions: Polycystic Kidney, Autosomal Dominant.
What interventions are being tested in trial NCT03342742?
The interventions under investigation include: Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03342742?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03342742 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Kidney, Autosomal Dominant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
ACTIVE NOT RECRUITING · Phase 2
-
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
COMPLETED · Phase 2
-
Effect of Venglustat in Patients With Renal Impairment
COMPLETED · Phase 1
-
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.